Market News (Page 93) - TendieTensor

Market News Page 93 of 159 • 3,965 articles

Chris Van Vliet Joins Cumulus Podcast Network

GlobeNewswire Inc. • Chris Van Vliet

Chris Van Vliet Joins Cumulus Podcast Network

11/06/2025 02:00 PM • Emmy Award-winning host Chris Van Vliet's popular wrestling and entertainment podcast 'INSIGHT' will now be distributed through the Cumulus Podcast Network, expanding its reach and potential audience.

GOOGL - Mentioned as a digital advertising and cloud computing competitor
CMLS - Expanding content portfolio by acquiring a top-rated podcast with nearly 2 million YouTube subscribers and strong brand recognition in wrestling entertainment

#podcast #wrestling #media #entertainment #distribution

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Golden Entertainment, Inc (Nasdaq - GDEN), Brighthouse Financial, Inc. (Nasdaq - BHF), Forge Global Holdings, Inc. (NYSE - FRGE), Hologic, Inc. (Nasdaq – HOLX)

GlobeNewswire Inc. • Brodsky & Smith

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Golden Entertainment, Inc (Nasdaq - GDEN), Brighthouse Financial, Inc. (Nasdaq - BHF), Forge Global Holdings, Inc. (NYSE - FRGE), Hologic, Inc. (Nasdaq – HOLX)

11/06/2025 01:54 PM • Law firm Brodsky & Smith is investigating potential breaches of fiduciary duties by boards of several companies during merger and acquisition transactions, focusing on whether shareholders are receiving fair value.

NVDA - Referenced for AI data center spending predictions
GDEN - Potential breach of fiduciary duties in merger with Blake Sartini and VICI Properties, questioning fairness of $30.00 per share consideration

#mergers #acquisitions #shareholder investigations #fiduciary duties

Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer

GlobeNewswire Inc. • Denny Lanfear

Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer

11/06/2025 01:54 PM • Coherus Oncology announced the appointment of Arvind Sood as Chief Strategy and Corporate Affairs Officer, focusing on advancing innovative cancer therapeutics and driving revenues for LOQTORZI®.

META - Mentioned as a digital advertising competitor
CHRS - Company is expanding leadership, highlighting strategic pipeline development in cancer therapies and potential business opportunities with global rights to key drug candidates

#oncology #biotechnology #cancer therapeutics #corporate development #investor relations

EV Battery Testing Market to Grow at 18.4% CAGR Through 2030

GlobeNewswire Inc. • Bcc Research

EV Battery Testing Market to Grow at 18.4% CAGR Through 2030

11/06/2025 01:35 PM • The global EV battery testing market is expected to expand from $4 billion in 2025 to $9.4 billion by 2030, driven by increasing EV sales, technological advances, and stringent safety regulations.

SGSOY - Deploying advanced AI-driven diagnostics and robotic testing rigs to accelerate battery performance testing

#EV battery testing #electric vehicles #battery safety #market growth #battery technologies

FIRETRAIL Investments Sells Off All 138K RYAN Shares Worth $9.3 Million

The Motley Fool • Adam Palasciano

FIRETRAIL Investments Sells Off All 138K RYAN Shares Worth $9.3 Million

11/06/2025 01:22 PM • Investment firm FIRETRAIL Investments completely sold its entire stake in Ryan Specialty Holdings, disposing of 137,533 shares worth approximately $9.32 million, signaling a strategic portfolio reallocation away from the specialty insurance sector.

TSLA - Mentioned for comparison of EBITDA margins, with Tesla at 17% compared to Ferrari's 38%, suggesting potential for improvement
RYAN - Stock has dropped 12% YTD, underperforming S&P 500 by 26.5 percentage points, with investor concerns about slowing growth and squeezed underwriting margins in the specialty insurance market

#investment #stock sale #specialty insurance #portfolio management

Novo Nordisk Has Downgraded Its Outlook for the Fourth Time This Year. Here's What Investors Need to Know.

The Motley Fool • Keith Speights

Novo Nordisk Has Downgraded Its Outlook for the Fourth Time This Year. Here's What Investors Need to Know.

11/06/2025 01:18 PM • Novo Nordisk reduced its 2025 sales and profit guidance due to slower growth in GLP-1 diabetes and obesity drugs, facing challenges from compounded medications and increased competition from Eli Lilly.

GM - Used as a comparative benchmark for valuation metrics, with a much lower P/E ratio than Ferrari
NVO - Downgraded full-year outlook for fourth time, lost 9% global market share, facing competition and compounding challenges

#GLP-1 #obesity drugs #pharmaceutical #earnings #guidance #Medicare

Apple: Why AI Caution May Become Its Advantage

Investing.com • Timothy Fries

Apple: Why AI Caution May Become Its Advantage

11/06/2025 01:05 PM • Apple's cautious approach to AI investment may prove strategic, as the company avoids massive capital expenditures while competitors rush into potentially overvalued AI technologies. The company's conservative strategy could protect it from potential AI market bubble risks.

AAPL - Demonstrated prudent AI investment strategy, maintained strong financial reserves, avoided excessive capital expenditure in AI, and positioned to weather potential market corrections

#AI #technology investment #market bubble #capital expenditure #tech strategy

Wilson Asset Eliminates Stake In 805K AVTR Shares Valued At $10.8 Million

The Motley Fool • Adam Palasciano

Wilson Asset Eliminates Stake In 805K AVTR Shares Valued At $10.8 Million

11/06/2025 01:04 PM • Wilson Asset Management completely sold its entire 805,658 share stake in Avantor, valued at $10.8 million, after the stock experienced a 45.8% decline over the past year, signaling a strategic portfolio reallocation.

AVTR - Stock declined 45.8% over the past year, experienced weaker demand from biopharma customers, and suffered from industry-wide inventory destocking

#asset management #stock divestment #life sciences #biopharma #portfolio reallocation

The Motley Fool • Rich Smith

Why Did Air Products Stock Pop Today?

11/06/2025 01:01 PM • Air Products reported Q4 earnings beating analyst expectations, with significant asset sale write-downs, and projected a return to profitability in fiscal 2026, leading to a 9.8% stock price increase.

APD - Despite reporting net losses in fiscal 2025, investors responded positively due to strong Q4 performance, beating earnings expectations, and management's optimistic fiscal 2026 earnings projection of $12.85 to $13.15 per share

#earnings #asset sales #fiscal performance #gases production

Global Oxygen Therapy Equipment Market is Predicted to Surge at ~8% CAGR by 2032 Owing to the Rising Respiratory Disorders and Technological Advancements | DelveInsight

GlobeNewswire Inc. • Delveinsight

Global Oxygen Therapy Equipment Market is Predicted to Surge at ~8% CAGR by 2032 Owing to the Rising Respiratory Disorders and Technological Advancements | DelveInsight

11/06/2025 01:00 PM • The global oxygen therapy equipment market is expected to grow from ~$3 billion in 2024 to ~$6 billion by 2032, driven by rising respiratory disorders, increased critical care utilization, and technological advancements in oxygen delivery systems.

INGN - Launched new stationary oxygen concentrator (Voxi 5), expanding product lineup and market opportunities

#oxygen therapy #respiratory disorders #medical devices #healthcare technology #COPD #asthma

NRG Energy Tops Q3 Earnings, $3B Share Repurchase Program Extends Through 2028

Benzinga • Lekha Gupta

NRG Energy Tops Q3 Earnings, $3B Share Repurchase Program Extends Through 2028

11/06/2025 12:51 PM • NRG Energy reported strong Q3 2025 financial results, beating revenue and earnings expectations, with increased operating income and cash flow. The company approved a $3 billion share repurchase program through 2028 and reaffirmed its annual financial outlook.

TECK - Mentioned as a past producer of a nearby mine, no direct involvement in current activities
NRG - Exceeded earnings expectations, increased operating income from -$812M to $414M, raised dividend, extended share repurchase program, and maintained strong financial outlook for 2025 and 2026

#earnings #share repurchase #dividend #financial performance

AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday?

Benzinga • Piero Cingari

AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday?

11/06/2025 12:45 PM • Markets experienced a risk-off sentiment on Thursday, with AI-linked stocks leading a broad selloff. Federal Reserve officials dampened hopes for rate cuts, and mixed corporate earnings contributed to market volatility.

HOOD - Stock plunged nearly 10% despite beating Wall Street expectations

#AI stocks #market selloff #Federal Reserve #earnings #crypto markets

Toll Brothers Announces New Phase of Luxury Homes at Toll Brothers at Creek Meadows West in Northlake, Texas

GlobeNewswire Inc. • Toll Brothers, Inc.

Toll Brothers Announces New Phase of Luxury Homes at Toll Brothers at Creek Meadows West in Northlake, Texas

11/06/2025 12:38 PM • Toll Brothers has launched a new phase of luxury single-family homes in Northlake, Texas, offering one-acre home sites starting from the low $900,000s within the Northwest Independent School District.

PRK - Limited information provided about the company beyond the proposed merger terms
TOL - Company is expanding its luxury home offerings in a desirable location, showcasing growth and market confidence through new community development and strategic positioning

#luxury homes #Texas real estate #single-family homes #Northlake

Can Gold Mining Stocks Shine as the Metals Rally Falters?

Investing.com • Nathan Reiff

Can Gold Mining Stocks Shine as the Metals Rally Falters?

11/06/2025 12:19 PM • Gold prices have pulled back from an all-time high of $4,400 to around $4,000, but remain up 48% year-to-date. Gold mining stocks like Barrick, Agnico Eagle, and Alamos are experiencing similar market dynamics, with analysts generally maintaining bullish outlooks despite potential challenges.

B - Doubled share price this year, strong Q2 earnings, increased dividend, and 13 out of 17 analysts recommend buying with 34% upside potential

#gold #mining stocks #metals rally #investment #commodities

Why Warby Parker Stock Is Plummeting Today

The Motley Fool • Josh Kohn-Lindquist

Why Warby Parker Stock Is Plummeting Today

11/06/2025 12:16 PM • Warby Parker's stock dropped 15% after missing Wall Street's Q3 revenue expectations, despite growing sales by 15% and improving margins. The company remains an underdog in the eyewear market with potential for growth, especially with AI-powered glasses.

ICE - Strategically invested $2 billion in Polymarket, positioning themselves as a stable infrastructure provider in the emerging prediction markets space
WRBY - Missed revenue expectations but showed operational growth and potential in AI-powered glasses market

#eyewear #direct-to-consumer #AI glasses #stock performance

3 Early Q3 Earnings Winners Setting the Tone for the Season Ahead

Investing.com • Damian Nowiszewski

3 Early Q3 Earnings Winners Setting the Tone for the Season Ahead

11/06/2025 12:12 PM • Early Q3 earnings season shows mixed results, with tech giants Alphabet and Amazon delivering strong performances, while Microsoft and Meta faced challenges. Eli Lilly also demonstrated impressive financial results, potentially targeting new stock price milestones.

DKNG - Potential future participant in prediction markets through potential acquisitions or platform development
GOOG - 25.3% earnings-per-share surprise, strong market reaction, stock riding an upward wave near $290 per share

#Q3 earnings #tech stocks #market performance #stock analysis

Why Firefly Aerospace Stock Just Crashed

The Motley Fool • Rich Smith

Why Firefly Aerospace Stock Just Crashed

11/06/2025 12:06 PM • Firefly Aerospace completed its $855 million acquisition of defense contractor SciTec, expanding its capabilities in space and defense sectors, but experienced a 12.5% stock price drop despite seemingly positive news.

FLY - Stock price dropped 12.5% after acquiring SciTec, but the acquisition appears strategically sound with a reasonable valuation of 5.2 times sales

#space stock #defense contractor #acquisition #stock market #SciTec

Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings

The Motley Fool • Jonathan Ponciano

Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings

11/06/2025 12:02 PM • Baltimore-based Brown Capital Management sold 861,020 shares of Vericel Corporation for approximately $31 million in Q3 2025, reducing its stake while the biotech company reported strong quarterly revenue growth of 17%.

VCEL - Mixed performance with 17% revenue growth but stock down 15% over past year, indicating potential market challenges

#biotech #cell therapy #stock sale #earnings #portfolio management

FTNT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fortinet, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

FTNT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fortinet, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

11/06/2025 12:00 PM • A class action lawsuit has been filed against Fortinet alleging false and misleading statements about FortiGate unit upgrades, revenue projections, and business prospects during the period of November 8, 2024 to August 6, 2025.

FTNT - The lawsuit alleges the company made materially false statements about product upgrades, revenue projections, and business sustainability, suggesting potential misrepresentation of financial performance and market potential

#class action #securities lawsuit #investor alert #FortiGate #revenue projection

IPSEN - Buy-back programme - Art 5 of MAR - Week 44 - 2025

GlobeNewswire Inc. • Na

IPSEN - Buy-back programme - Art 5 of MAR - Week 44 - 2025

11/06/2025 12:00 PM • Ipsen reported its share transactions for the period of October 27th to October 31st, 2025, detailing daily trading volumes and weighted average purchase prices across multiple markets.

IPSEY - The article is a factual report of share transactions without indicating positive or negative performance, presenting routine market activity data

#share transactions #stock trading #market report

Chiffre d’affaires du 3ème trimestre 2025 : 48,7 M€

GlobeNewswire Inc. • Aurea

Chiffre d’affaires du 3ème trimestre 2025 : 48,7 M€

11/06/2025 12:00 PM • AUREA reported a 14% decline in Q3 2025 revenue to €48.7M, impacted by US trade tariffs and raw material shortages. The group remains cautious about future performance amid geopolitical uncertainties while focusing on operational efficiency and strategic adaptations.

EPR - Continuing growth trajectory, supported by ongoing development in oil waste and polluted water treatment

#revenue #circular economy #waste regeneration #trade tariffs #economic uncertainty

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 44 - 2025

GlobeNewswire Inc. • Na

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 44 - 2025

11/06/2025 12:00 PM • Ipsen reported its share buyback transactions from October 27-31, 2025, detailing daily trading volumes and weighted average purchase prices across multiple stock exchanges.

IPSEY - The document is a routine financial transaction report showing standard share buyback activities without indicating significant positive or negative market implications

#buyback #stock transactions #financial reporting

Higher-Dose Of Wegovy Demonstrates Weight Loss And Cardiovascular Benefits

Benzinga • Vandana Singh

Higher-Dose Of Wegovy Demonstrates Weight Loss And Cardiovascular Benefits

11/06/2025 11:45 AM • Novo Nordisk presented new findings from the STEP UP trial showing Wegovy helps obese people lose an average of 21% body weight and achieve cardiovascular health improvements with both 2.4 mg and 7.2 mg doses.

B - Mentioned as previous employer of Katy Grant, with no specific positive or negative context
NVO - Demonstrated significant clinical trial results for weight loss drug, showing potential for expanded treatment options and improved patient outcomes with both current and investigational drug doses

#Wegovy #weight loss #obesity #cardiovascular health #semaglutide

Pfizer To Raise Metsera Bid After Court Denies Attempt To Block Rival Deal

Benzinga • Vandana Singh

Pfizer To Raise Metsera Bid After Court Denies Attempt To Block Rival Deal

11/06/2025 11:40 AM • Delaware Chancery Court denied Pfizer's request to prevent Metsera from terminating their merger agreement in favor of Novo Nordisk's competing proposal. Pfizer plans to raise its bid and challenges the legality of Novo Nordisk's transaction structure.

PFE - Actively pursuing the acquisition by preparing to raise its bid and challenging the rival deal legally

#merger #acquisition #antitrust #biotech #court ruling

Lamar Advertising (LAMR) Q3 2025 Earnings Call Transcript

The Motley Fool • Motley Fool Transcribing

Lamar Advertising (LAMR) Q3 2025 Earnings Call Transcript

11/06/2025 11:10 AM • Lamar Advertising reported accelerating acquisition-adjusted revenue growth of 2.9% in Q3 2025, driven by strong national programmatic advertising and digital billboard performance. The company remains optimistic about 2026, with strong customer commitments and potential political advertising tailwinds.

GOOG - Providing $1.3 billion backstop for data center financing, indicating strategic interest
LAMR - Strong Q3 performance with 2.9% revenue growth, positive outlook for 2026, robust programmatic and digital advertising growth, and strategic acquisitions

#advertising #out-of-home media #digital billboards #programmatic advertising #revenue growth